Table 1 Clinicopathological factors of patients in the study
From: A molecular and staging model predicts survival in patients with resected non-small cell lung cancer
Variables | No. | Percent |
|---|---|---|
Age (years) | ||
< 60 | 63 | 41.4 |
≥ 60 | 89 | 58.6 |
Gender | ||
Male | 83 | 54.6 |
Female | 69 | 45.4- |
Smoking status | ||
Never-smoker | 64 | 42.1 |
Ever-smoker | 88 | 57.9 |
TNM stage | ||
I | 53 | 34.9 |
II | 51 | 33.6 |
III | 48 | 31,5 |
Grade | ||
Well-differentiated | 32 | 21.1 |
Moderately-differentiated | 66 | 43.4 |
Poorly-differentiated | 54 | 35.5 |
Histology | ||
Squamous cell carcinoma | 39 | 25.7 |
Adenocarcinoma | 113 | 74.3 |
Postoperative adjuvant therapy | ||
Yes | 84 | 55.3 |
No | 68 | 44.7 |